Literature DB >> 14695534

Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: maximum entropy estimates of splice junction strengths.

Laura Eng1, Gabriela Coutinho, Shareef Nahas, Gene Yeo, Robert Tanouye, Mahnoush Babaei, Thilo Dörk, Christopher Burge, Richard A Gatti.   

Abstract

Ataxia-telangiectasia (A-T) is an autosomal recessive neurological disorder caused by mutations in the ATM gene. Classical splicing mutations (type I) delete entire exons during pre-mRNA splicing. In this report, we describe nine examples of nonclassical splicing mutations in 12 A-T patients and compare cDNA changes to estimates of splice junction strengths based on maximum entropy modeling. These mutations fall into three categories: pseudoexon insertions (type II), single nucleotide changes within the exon (type III), and intronic changes that disrupt the conserved 3' splice sequence and lead to partial exon deletion (type IV). Four patients with a previously reported type II (pseudoexon) mutation all shared a common founder haplotype. Three patients with apparent missense or silent mutations actually had type III aberrant splicing and partial deletion of an exon. Five patients had type IV mutations that could have been misinterpreted as classical splicing mutations. Instead, their mutations disrupt a splice site and use another AG splice site located nearby within the exon; they lead to partial deletions at the beginning of exons. These nonclassical splicing mutations create frameshifts that result in premature termination codons. Without screening cDNA or using accurate models of splice site strength, the consequences of these genomic mutations cannot be reliably predicted. This may lead to further misinterpretation of genotype-phenotype correlations and may subsequently impact upon gene-based therapeutic approaches. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14695534     DOI: 10.1002/humu.10295

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  66 in total

Review 1.  Clinical correlation and molecular evaluation confirm that the MLH1 p.Arg182Gly (c.544A>G) mutation is pathogenic and causes Lynch syndrome.

Authors:  Michael P Farrell; David J Hughes; Ian R Berry; David J Gallagher; Emily A Glogowski; Stewart J Payne; Michael J Kennedy; Róisín M Clarke; Susan A White; Cian B Muldoon; Fiona Macdonald; Pauline Rehal; Danielle Crompton; Solvig Roring; Sarah T Duke; Trudi McDevitt; David E Barton; Shirley V Hodgson; Andrew J Green; Peter A Daly
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

2.  Functional characterization and targeted correction of ATM mutations identified in Japanese patients with ataxia-telangiectasia.

Authors:  Kotoka Nakamura; Liutao Du; Rashmi Tunuguntla; Francesca Fike; Simona Cavalieri; Tomohiro Morio; Shuki Mizutani; Alfredo Brusco; Richard A Gatti
Journal:  Hum Mutat       Date:  2011-11-09       Impact factor: 4.878

3.  An apparent pseudo-exon acts both as an alternative exon that leads to nonsense-mediated decay and as a zero-length exon.

Authors:  Sushma-Nagaraja Grellscheid; Christopher W J Smith
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

4.  Evolutionary divergence of exon flanks: a dissection of mutability and selection.

Authors:  Yi Xing; Qi Wang; Christopher Lee
Journal:  Genetics       Date:  2006-05-15       Impact factor: 4.562

5.  Identification of seven novel cryptic exons embedded in the dystrophin gene and characterization of 14 cryptic dystrophin exons.

Authors:  Zhujun Zhang; Yasuaki Habara; Atsushi Nishiyama; Yoshinobu Oyazato; Mariko Yagi; Yasuhiro Takeshima; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2007-06-20       Impact factor: 3.172

6.  Arginine-rich cell-penetrating peptide dramatically enhances AMO-mediated ATM aberrant splicing correction and enables delivery to brain and cerebellum.

Authors:  Liutao Du; Refik Kayali; Carmen Bertoni; Francesca Fike; Hailiang Hu; Patrick L Iversen; Richard A Gatti
Journal:  Hum Mol Genet       Date:  2011-05-16       Impact factor: 6.150

7.  A splice site mutation in a gene encoding for PDK4, a mitochondrial protein, is associated with the development of dilated cardiomyopathy in the Doberman pinscher.

Authors:  Kathryn M Meurs; Sunshine Lahmers; Bruce W Keene; Stephen N White; Mark A Oyama; Evan Mauceli; Kerstin Lindblad-Toh
Journal:  Hum Genet       Date:  2012-03-25       Impact factor: 4.132

Review 8.  SMRT compounds correct nonsense mutations in primary immunodeficiency and other genetic models.

Authors:  Richard A Gatti
Journal:  Ann N Y Acad Sci       Date:  2012-02       Impact factor: 5.691

9.  Molecular characterization of Portuguese patients with mucopolysaccharidosis type II shows evidence that the IDS gene is prone to splicing mutations.

Authors:  S Alves; M Mangas; M J Prata; G Ribeiro; L Lopes; H Ribeiro; J Pinto-Basto; M Reis Lima; L Lacerda
Journal:  J Inherit Metab Dis       Date:  2006-10-25       Impact factor: 4.982

10.  A comprehensive survey of human polymorphisms at conserved splice dinucleotides and its evolutionary relationship with alternative splicing.

Authors:  Makoto K Shimada; Yosuke Hayakawa; Jun-ichi Takeda; Takashi Gojobori; Tadashi Imanishi
Journal:  BMC Evol Biol       Date:  2010-04-30       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.